Pan, J., Li, Q., Zhang, L., Jia, L., Tang, J., Bao, Y., et al. (2014) Serum Glycated Albumin Predicts the Progression of Diabetic Retinopathy—A Five Year Retrospective Longitudinal Study. Journal of Diabetes and Its Complications, 28, 772-778.
https://doi.org/10.1016/j.jdiacomp.2014.06.015

has been cited by the following article:

• TITLE: Association of GA/HbA1c Ratio with Diabetic Retinopathy

  AUTHORS: Tianyao Zhang, Xu Zheng

  KEYWORDS: Type 2 Diabetes, Diabetic Retinopathy, GA/HbA1c Ratio

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.14 No.8, August 10, 2023

  ABSTRACT: Objectives: The aim of this study was to explore the potential correlation between the GA/HbA1c ratio and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D), as the GA/HbA1c ratio serves as a marker for glycemic variability. Methods: A total of 2565 T2D patients were included in this study and grouped into five categories based on the diagnostic criteria for DR. We examined the impact of the GA/HbA1c ratio on the progression of diabetes. Results: The non-DR group exhibited lower GA/HbA1c levels compared to the DR group. Additionally, as the severity of DR increased among the five groups, there was a corresponding increase in the GA/HbA1c ratio. Logistic regression analysis demonstrated that the GA/HbA1c ratio independently elevated the risk of DR occurrence. Conclusions: The GA/HbA1c ratio can independently predict the occurrence and progression of diabetic retinopathy.